Valuation: Sartorius Stedim Biotech S.A.

Market Cap 21.74B 24.27B 19.99B 18.12B 33.86B 2,304B 34.5B 238B 95.71B 1,212B 91.08B 89.15B 3,823B P/E 2026 *
56.5x
P/E 2027 * 43.5x
Enterprise Value 23.72B 26.49B 21.82B 19.77B 36.96B 2,515B 37.65B 260B 104B 1,323B 99.41B 97.3B 4,172B EV / Sales 2026 *
7.57x
EV / Sales 2027 * 6.72x
Free-Float
28.47%
Yield 2026 *
0.37%
Yield 2027 * 0.44%
1 day-2.01%
1 week+5.89%
1 month-2.67%
3 months+29.49%
6 months+35.57%
Current year+4.38%
1 week 23.61
Extreme 23.61
25.74
1 month 22.37
Extreme 22.37
25.74
Current year 17.25
Extreme 17.25
26.54
1 year 17.25
Extreme 17.25
26.54
3 years 15.75
Extreme 15.75
30.62
5 years 15.75
Extreme 15.75
43.52
10 years 15.75
Extreme 15.75
43.52
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 62 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 70 2015-04-06
Director/Board Member 69 2017-09-13
Change 5-day change 1-year change 3-year change Capi.($)
-2.01%+5.89% - - 24.27B
+1.56%+2.41%-14.09%+12.32% 184B
-0.59%+1.18%+6.44%+36.82% 118B
-6.38%-4.98%-18.07%+8.01% 111B
+3.42%+1.71%-41.92%+8.01% 94.58B
+0.09%-0.05%-2.06%+78.69% 63.13B
-0.46%+0.42%+4.48%+82.84% 55.66B
-0.23%-0.52%+10.73%-21.72% 53.9B
-4.30%-1.64%-12.44%+37.99% 43.42B
+0.58%+2.00%-1.17%-8.82% 34.68B
Average -0.83%+0.06%-7.57%+26.01% 84.27B
Weighted average by Cap. -0.53%+0.24%-10.13%+23.75%

Financials

2026 *2027 *
Net sales 3.13B 3.5B 2.88B 2.61B 4.88B 332B 4.97B 34.38B 13.8B 175B 13.13B 12.85B 551B 3.49B 3.9B 3.21B 2.91B 5.44B 370B 5.54B 38.29B 15.37B 195B 14.63B 14.32B 614B
Net income 384M 429M 353M 320M 598M 40.71B 609M 4.21B 1.69B 21.41B 1.61B 1.57B 67.53B 489M 546M 450M 408M 762M 51.88B 777M 5.37B 2.15B 27.29B 2.05B 2.01B 86.06B
Net Debt 1.99B 2.22B 1.83B 1.66B 3.1B 211B 3.15B 21.8B 8.75B 111B 8.33B 8.15B 350B 1.73B 1.93B 1.59B 1.44B 2.7B 183B 2.75B 18.98B 7.62B 96.48B 7.25B 7.09B 304B
Projected Income Statement - Annual - Sartorius Stedim Biotech S.A.
Logo Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,483
Date Price Change Volume
26-10-30 US$24.81 -2.01% 10,173
26-10-29 US$25.32 +2.84% 14,003
26-10-28 US$24.62 +0.94% 11,548
26-10-27 US$24.39 +1.39% 17,382
26-10-26 US$24.06 +2.67% 30,683
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Sartorius Stedim Biotech S.A.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
223.40EUR
Average target price
247.14EUR
Spread / Average Target
+10.63%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sartorius Stedim Biotech S.A.